Market Research Logo

Recombinant Therapeutic Antibodies and Proteins Market - Size, Share, trends, and Forecast to 2026

Recombinant Therapeutic Antibodies and Proteins Market - Size, Share, trends, and Forecast to 2026

Recombinant therapeutic protein drugs are an important class of medicines, which helps patients in need of novel therapies. Recently approved recombinant protein therapeutics have been developed to treat a wide variety of clinical indications, including cancers, inflammation/autoimmunity, genetic disorders, and exposure to infectious agents. The latest advancements in protein-engineering technologies have allowed drug manufacturers and developers to adjust desirable functional characteristics of proteins of interest maintaining product efficacy. Protein-based therapies are highly successful and experience unparalleled growth potential in terms of their efficacy.
Market Dynamics
Recombinant therapeutic proteins and antibodies have gained high traction in clinical applications. Due to development of antibody-based therapeutics, mammalian expression systems have experienced a major boost and microbial expression systems continue to be widely used in industries, which in turn will fuel growth of the market. However, variations in production methods of therapeutic antibodies can lead to differences in their structure, based on the selection of recombinant procedure. Most protein therapeutics available in the market are recombinant and majority of them are in clinical trials for therapy of immune disorders, cancers, infections, and other diseases. Various engineered proteins, including multi-specific fusion proteins, bi-specific monoclonal antibodies (mAbs) and mAbs conjugated small molecule drugs, and proteins with optimized pharmacokinetics are under development.
Key features of the study:

This report provides in-depth analysis of recombinant therapeutic antibodies and proteins market and provides market size (US$ Million) and cumulative annual growth rate (CAGR %) for the forecast period (2018 – 2026), considering 2017 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global recombinant therapeutic antibodies and proteins market based on the following parameters – company overview, financial performance, product portfolio, market presence, key developments, strategies, and future plans
Key companies covered as a part of this study include Abbott, Amgen Inc., Biogen Inc., Eli Lilly and Company, F. Hoffmann-La Roche, Johnson and Johnson, Merck & Co., Novo Nordisk, Pfizer Inc., and Sanofi S.A.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global recombinant therapeutic antibodies and proteins market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the recombinant therapeutic antibodies and proteins market

Detailed Segmentation:

Global Recombinant Therapeutic Antibodies and Proteins Market, By Drug Class:

Plasma Protein
Growth Factors
Fusion Proteins
Monoclonal Antibodies
Hormones
Enzyme
Coagulation Factors
Others

Global Recombinant Therapeutic Antibodies and Proteins Market, By Application:

Oncology
Hematology
Immunology
Endocrinology
Infectious Disease
Cardiovascular Diseases
Others

Global Recombinant Therapeutic Antibodies and Proteins Market, By Geography:

North America Recombinant Therapeutic Antibodies and Proteins Market

By Drug Class:

Plasma Protein
Growth Factors
Fusion Proteins
Monoclonal Antibodies
Hormones
Enzyme
Coagulation Factors
Others

By Application:

Oncology
Hematology
Immunology
Endocrinology
Infectious Disease
Cardiovascular Diseases
Others

By Country:

U.S.
Canada

Latin America Recombinant Therapeutic Antibodies and Proteins Market

By Drug Class:

Plasma Protein
Growth Factors
Fusion Proteins
Monoclonal Antibodies
Hormones
Enzyme
Coagulation Factors
Others

By Application:

Oncology
Hematology
Immunology
Endocrinology
Infectious Disease
Cardiovascular Diseases
Others

By Country:

Brazil
Mexico
Argentina
Rest of Latin America

Europe Recombinant Therapeutic Antibodies and Proteins Market

By Drug Class:

Plasma Protein
Growth Factors
Fusion Proteins
Monoclonal Antibodies
Hormones
Enzyme
Coagulation Factors
Others

By Application:

Oncology
Hematology
Immunology
Endocrinology
Infectious Disease
Cardiovascular Diseases
Others

By Country:

Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe

Asia Pacific Recombinant Therapeutic Antibodies and Proteins Market

By Drug Class:

Plasma Protein
Growth Factors
Fusion Proteins
Monoclonal Antibodies
Hormones
Enzyme
Coagulation Factors
Others

By Application:

Oncology
Hematology
Immunology
Endocrinology
Infectious Disease
Cardiovascular Diseases
Others

By Country:

China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific

Middle East Recombinant Therapeutic Antibodies and Proteins Market

By Drug Class:

Plasma Protein
Growth Factors
Fusion Proteins
Monoclonal Antibodies
Hormones
Enzyme
Coagulation Factors
Others

By Application:

Oncology
Hematology
Immunology
Endocrinology
Infectious Disease
Cardiovascular Diseases
Others

By Country:

GCC
Israel
Rest of Middle East

Africa Recombinant Therapeutic Antibodies and Proteins Market

By Drug Class:

Plasma Protein
Growth Factors
Fusion Proteins
Monoclonal Antibodies
Hormones
Enzyme
Coagulation Factors
Others

By Application:

Oncology
Hematology
Immunology
Endocrinology
Infectious Disease
Cardiovascular Diseases
Others

By Country:

North Africa
South Africa
Central Africa

Company Profiles

Abbott Laboratories*

Company Overview
Product Portfolio
Key Highlights
Financial Overview
Market Strategy

Amgen Inc.
Biogen Inc.
Eli Lilly and Company
F. Hoffmann-La Roche
Johnson and Johnson
Merck & Co.
Novo Nordisk
Pfizer, Inc.
Sanofi S.A.

“*” marked represents similar segmentation in other categories in the respective section.


Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Drug Class
Market Snippet, By Application
Market Snippet, By Region
Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Market Trends
Pipeline Analysis
Drug Development Challenges
New Market Entrants
Regulatory Scenario
PEST Analysis
Porter’s Analysis
Global Recombinant Therapeutic Antibodies and Proteins Market, By Drug Class, 2016 – 2026, (US$ Million)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017–2026
Segment Trends
Plasma Protein
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Growth Factors
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Fusion Proteins
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Monoclonal Antibodies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Hormones
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Enzyme
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Coagulation Factors
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Global Recombinant Therapeutic Antibodies and Proteins Market, Application, 2016 – 2026, (US$ Million)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017–2026
Segment Trends
Oncology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Hematology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Immunology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Endocrinology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Infectious Disease
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Cardiovascular Disease
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Global Recombinant Therapeutic Antibodies and Proteins Market, By Region, 2016 – 2026, (US$ Million)
Introduction
Market Share Analysis, By Region, 2018 and 2026 (%)
Y-o-Y Growth Analysis, For Regions, 2017–2026
Regional Trends
North America
Market Size and Forecast, By Drug Class, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
U.S.
Canada
Latin America
Market Size and Forecast, By Drug Class, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Market Size and Forecast, By Drug Class, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Drug Class, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
Market Size and Forecast, By Drug Class, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
GCC
Israel
Rest of Middle East
Africa
Market Size and Forecast, By Drug Class, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
South Africa
Central Africa
North Africa
Competitive Landscape
Heat Map Analysis
Company Profiles
Abbott*
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Market Strategy
Amgen Inc.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Market Strategy
Biogen Inc.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Market Strategy
Eli Lilly and Company
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Market Strategy
F. Hoffmann-La Roche
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Market Strategy
Johnson and Johnson
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Market Strategy
Merck & Co.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Market Strategy
Novo Nordisk
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Market Strategy
Pfizer Inc.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Market Strategy
Sanofi S.A.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Market Strategy
Analyst Views
Section
References
Research Methodology
About us and Sales Contact
*Browse 22 market data tables and 27figures on \Recombinant Therapeutic Antibodies and Proteins Market - Global forecast to 2026”.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report